New Ingredients, New Life For Cytodyne’s Weight Loss Supplements
This article was originally published in The Tan Sheet
Executive SummaryA firm that has agreed to pay as much as $12.8 million to settle a false advertising complaint and that reorganized under bankruptcy protection after incurring losses from ephedra-related lawsuits is returning to the marketplace with a new weight loss supplement, according to a Jan. 15 announcement
You may also be interested in...
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.